Abstract:Wei, Slowikowski, Fonseka, Rao et al A single cell map of the RA joint Abstract 78 To define the cell populations in rheumatoid arthritis (RA) driving joint inflammation, we applied 79 single-cell RNA-seq (scRNA-seq), mass cytometry, bulk RNA-seq, and flow cytometry to sorted 80 T cells, B cells, monocytes, and fibroblasts from 51 synovial tissue RA and osteoarthritis (OA) 81 patient samples. Utilizing an integrated computational strategy based on canonical correlation 82 analysis to 5,452 scRNA-seq profiles, … Show more
“…These synovial DCs are generally mature and NF-κB is over-expressed. Multiple subsets of MHC class II + APCs are present in RA synovial tissue, including Toll-like receptor (TLR)-activated myeloid-derived cells, CD11c + CD20 + activated B cells and MHC class II hi fibroblast-like synoviocytes [30]. Multiple subsets of MHC class II + APCs are present in RA synovial tissue, including Toll-like receptor (TLR)-activated myeloid-derived cells, CD11c + CD20 + activated B cells and MHC class II hi fibroblast-like synoviocytes [30].…”
Dendritic cells (DCs) are the key professional antigen-presenting cells which bridge innate and adaptive immune responses, inducing the priming and differentiation of naive to effector CD4 + T cells, the cross-priming of CD8 + T cells and the promotion of B cell antibody responses. DCs also play a critical role in the maintenance of immune homeostasis and tolerance. DC-T cell interactions underpin the generation of an autoimmune response in rheumatoid arthritis (RA). Here we describe the function of DCs and review evidence for DC and T cell involvement in RA pathogenesis, in particular through the presentation of self-peptide by DCs that triggers differentiation and activation of autoreactive T cells. Finally, we discuss the emerging field of targeting the DC-T cell interaction for antigen-specific immunotherapy of RA.
“…These synovial DCs are generally mature and NF-κB is over-expressed. Multiple subsets of MHC class II + APCs are present in RA synovial tissue, including Toll-like receptor (TLR)-activated myeloid-derived cells, CD11c + CD20 + activated B cells and MHC class II hi fibroblast-like synoviocytes [30]. Multiple subsets of MHC class II + APCs are present in RA synovial tissue, including Toll-like receptor (TLR)-activated myeloid-derived cells, CD11c + CD20 + activated B cells and MHC class II hi fibroblast-like synoviocytes [30].…”
Dendritic cells (DCs) are the key professional antigen-presenting cells which bridge innate and adaptive immune responses, inducing the priming and differentiation of naive to effector CD4 + T cells, the cross-priming of CD8 + T cells and the promotion of B cell antibody responses. DCs also play a critical role in the maintenance of immune homeostasis and tolerance. DC-T cell interactions underpin the generation of an autoimmune response in rheumatoid arthritis (RA). Here we describe the function of DCs and review evidence for DC and T cell involvement in RA pathogenesis, in particular through the presentation of self-peptide by DCs that triggers differentiation and activation of autoreactive T cells. Finally, we discuss the emerging field of targeting the DC-T cell interaction for antigen-specific immunotherapy of RA.
“…In rheumatoid arthritis (RA), analysis of synovial tissue with single‐cell RNA sequencing and cytometry by time‐of‐flight mass spectrometry have revealed discrete cell subpopulations with transcriptomic and cell surface expression profiles linked to functional activities . These analyses, focused on the synovium and not the peripheral blood, provided new insights regarding key pathogenic cell–cell interactions and underscore the necessity of examining cellular and molecular events in the target tissue.…”
Section: Characteristics Of Tissue‐resident Memory T Cellsmentioning
“…The ABF is defined as the likelihood ratio of the probability of observing an effect size according to a normal distribution (mean 0, variance equal to the variance of all effect sizes) to the probability of observing the same effect size according to a normal distribution with wider variance, eg adjusted for a prior of observing an odds ratio of 1.5. Of the RA‐associated putatively causal variants, we rediscovered missense variants in PTPN22 and TYK2 and found a novel missense variant rs35677470 in DNASE1L3 (expressed in stromal fibroblasts) and noncoding variants in CD28‐CTLA4 (rs55686954, rs117701653) and TNFAIP3 (rs35926684). The noncoding variants rs117701653 and rs35926684, near CD28‐CTLA4 and TNFAIP3 , respectively, exhibited allele‐specific protein binding activity (electrophoretic mobility shift assay (EMSA)) and CD4 + T cell specific differential enhancer activity (Luciferase reporter assay).…”
Section: Identifying Causal Variants Among Genome‐wide Associations Wmentioning
confidence: 99%
“…One such initiative is the Accelerating Medicines Partnership, which in its first phase profiled more than 5000 cells in 36 RA patients and 15 osteoarthritis (OA) controls. Our group developed a CCA graph‐based clustering strategy to identify single cell populations by leveraging correlated regulatory structure with bulk reference samples . As a result, 3 CD4 + T cell subtypes were identified with distinct expression profiles, CCR7+ T cells, Tregs, and a mix of T peripheral (Tph) and follicular (Tfh) helper cells.…”
Section: Single Cell Transcriptomic and Epigenomic Advancesmentioning
confidence: 99%
“…Our group developed a CCA graphbased clustering strategy to identify single cell populations by leveraging correlated regulatory structure with bulk reference samples. 51 As a re-…”
Section: S Ing Le Cell Tr An Scrip Tomi C and Epig Enomic Advan Ce Smentioning
Summary
Rheumatoid arthritis (RA) risk has a large genetic component (~60%) that is still not fully understood. This has hampered the design of effective treatments that could promise lifelong remission. RA is a polygenic disease with 106 known genome‐wide significant associated loci and thousands of small effect causal variants. Our current understanding of RA risk has suggested cell‐type‐specific contexts for causal variants, implicating CD4 + effector memory T cells, as well as monocytes, B cells and stromal fibroblasts. While these cellular states and categories are still mechanistically broad, future studies may identify causal cell subpopulations. These efforts are propelled by advances in single cell profiling. Identification of causal cell subpopulations may accelerate therapeutic intervention to achieve lifelong remission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.